USFDA settlement to hit Ranbaxy by Rs 60/sh: Espirito Santo
Ranbaxy Laboratories said it has reached a settlement with the US Food and Drug Administration while setting aside USD 500 million to address its potential liability from a separate US Justice Department investigation.